Yuichi Wakabayashi

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Venues

Cancer science

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuhiro Okumura, Takao Morinaga, Megumi Saito, Yurika Tokunaga, Keisuke Otoyama, Sora Tanaka, Eriko Isogai, Masahito Kawazu, Yosuke Togashi, Yoshinori Hasegawa, Yuichi Wakabayashi
Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model. Cancer science (2024)
Kazuhiro Okumura, Takao Morinaga, Megumi Saito, Yurika Tokunaga, Keisuke Otoyama, Sora Tanaka, Eriko Isogai, Masahito Kawazu, Yosuke Togashi, Yoshinori Hasegawa, Yuichi Wakabayashi
Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model. Cancer science 115 (8) (2024)
Kazuhiro Okumura, Takao Morinaga, Megumi Saito, Yurika Tokunaga, Keisuke Otoyama, Sora Tanaka, Eriko Isogai, Masahito Kawazu, Yosuke Togashi, Yoshinori Hasegawa, Yuichi Wakabayashi
Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model. Cancer science (2024)
Kazuhiro Okumura, Takao Morinaga, Megumi Saito, Yurika Tokunaga, Keisuke Otoyama, Sora Tanaka, Eriko Isogai, Masahito Kawazu, Yosuke Togashi, Yoshinori Hasegawa, Yuichi Wakabayashi
Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model. Cancer science 115 (8) (2024)
Kazuhiro Okumura, Takao Morinaga, Megumi Saito, Yurika Tokunaga, Keisuke Otoyama, Sora Tanaka, Eriko Isogai, Masahito Kawazu, Yosuke Togashi, Yoshinori Hasegawa, Yuichi Wakabayashi
Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model. Cancer science 115 (8) (2024)
Kazuhiro Okumura, Megumi Saito, Eriko Isogai, Yuichi Wakabayashi
The Japanese Wild-Derived Inbred Mouse Strain, MSM/Ms in Cancer Research. Cancers 13 (5) (2021)
Megumi Saito, Naoko Kagawa, Kazuhiro Okumura, Haruka Munakata, Eriko Isogai, Tatsuo Fukagawa, Yuichi Wakabayashi
CENP-50 is required for papilloma development in the two-stage skin carcinogenesis model. Cancer science 111 (8) (2020)
Kazuhiro Okumura, Naoko Kagawa, Megumi Saito, Yasuhiro Yoshizawa, Haruka Munakata, Eriko Isogai, Tatsuo Fukagawa, Yuichi Wakabayashi
CENP-R acts bilaterally as a tumor suppressor and as an oncogene in the two-stage skin carcinogenesis model. Cancer science 108 (11) (2017)

Yuichi Wakabayashi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yuichi Wakabayashi